Sanjay Chanda, Chief Development Officer at AN2 Therapeutics, Inc. (ANTX), sold 2,957 shares at $1.34 ($4K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $4k ANTX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAC | SELL | 2014-12-01 | $175K | — | Filing → |
| ANAC | SELL | 2014-09-12 | $243K | — | Filing → |